Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar Bungi82 (< 20) Submitted: 7/4/2008 4:25:37 AM : Outperform Start Price: $4.43 TCM Score: -7.26

BUY!

Featured Broker Partners


Advertisement